Pediatr. praxi. 2022;23(6):394-396 | DOI: 10.36290/ped.2022.070

Intestinal parasites in children yesterday, today and tomorrow

Mgr. Hana Bílková Fránková, MBA1, MUDr. Jan Boženský2, MUDr. Anna Mikošková2
1 Oddělení klinické mikrobiologie, Laboratoře AGEL, Ostrava-Vítkovice
2 Dětské oddělení, Nemocnice AGEL, Ostrava-Vítkovice

The incidence of intestinal parasites in the population is decreasing according to the Information System of Infectious Diseases. Detection is affected by the accuracy of stool collection and the method by which the sample is examined. Based on PCR diagnostics of stool samples from 200 children, we showed that parasitosis prevalence is higher than the data described. Clinical symptoms and positivity in our study do not correlate. Eradication of asymptomatic individuals should always be considered given the emerging evidence that there is an indirect relationship between the prevalence of intestinal parasitosis and the incidence of allergies, autoimmunity, Crohn's disease, etc., as well as the unclear pathogenicity of some of the microorganisms.

Keywords: Dientamoeba fragilis, Blastocystis hominis, Enterobius vermicularis, PCR diagnostics, parasite.

Accepted: November 16, 2022; Published: November 22, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bílková Fránková H, Boženský J, Mikošková A. Intestinal parasites in children yesterday, today and tomorrow. Pediatr. praxi. 2022;23(6):394-396. doi: 10.36290/ped.2022.070.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Hozáková L. Parazitární nemoci u dětí způsobené endoparazity. Pediatr. praxi. 2015;16(4):251-255.
    2. Vaništa J. Střevní parazitózy. In: Cls.cz [Internet]. [cited 5-9-2021]. Available from: https://www.cls.cz/seznam-doporucenych-postupu.
    3. Omar MA, Amin KO. An Eighteen Year Study of Intestinal Protozoans in the Los Angelss Area Between 1996 and 2013. EC Gastroenterology and Digestive System 2. 2017(6):494-504.
    4. ISIN. Available from http://www.szu.cz/publikace/data.
    5. Doležílková J. Parazitární nákazy u dětí v České republice. Pediatr. praxi. 2017;18(6):227-229. Go to original source...
    6. Ditrich O. Současná rizika parazitárních infekcí u dětí v ČR. VOX Pediatrie. 2017;17(8):18-23.
    7. Lynne S. Garcia. Dientamoeba fragilis, One of the Neglected Intestinal Protozoa. Journal of clinical Microbiology. 2016;54(9):2243-2250. Go to original source... Go to PubMed...
    8. Banik G, Barratt J, Marriott D, et al. A case-controlled study of Dientamoeba fragilis infections in children. Parasitology. 2011;138(7):819-823. Go to original source... Go to PubMed...
    9. Hellemond J, Molhoek N, Koelewijn R, et al. Is paromomycin the drug of choice for eradication of Dientamoeba fragilis in adults? Int. J. Parasitol Drougs Drug Resistance. 2012;2:162-165. Go to original source... Go to PubMed...
    10. Röser D, Simonsen J, Stensvold Ch, et al. Metronidazole Therapy for Treating Dientamoebiasis in Children Is Not Associated With Better Clinical Outcomes: A Randomized, Double-Blinded and Placebo-Controlled Clinical Trial. Clin. Infect. Dis. 2014;58(12):1692-1699. Go to original source... Go to PubMed...
    11. Nohýnková E. Dientamoeba fragilis - opomíjený patogen lidského střeva. Seminář Oportunní a opomíjené protozoární střevní nákazy: sborník příspěvků. Praha 1. 3. 2005. Praha: Praha Lékařský dům ČLS JEP; 2005.
    12. Beyhan Y, Yilmaz H, Cengiz Z, et al. Clinical, signifikance and prevalence of Blastocystis hominis in Van, Turkey. Saudi Med. J. 2015;36(9):1118-1121. Go to original source... Go to PubMed...
    13. Yason J, LIang Y, Png Ch, et al. Interactions between a pathogenic Blastocystis subtype and gut mikrobiota: in vitro and in vivo studies. Microbiome. 2019;11 March. doi: https://doi.org/10.1186/s40168-019-0644-3. Go to original source... Go to PubMed...
    14. Lorencová M. Diverzita rodu Blasto-cystis (Stramenopiles). In: Dspace.cuni.cz [internet]. [cit. 5-9-2021]. Available from: https://dspace.cuni.cz/handle/20.500.11956/67764.
    15. Kataki M, Tavalla M, Beiromvand M. Higher prevalence of Blastocystis hominis in healthy individuals than patients with gastrointestinal symptomas from Ahvaz, southwestern Iran. Comp. Immunol. Microbiol. Infect. Dis. 2019;65:160-164. Go to original source... Go to PubMed...
    16. Rostami A, Riahi S, Haghighi A, et al. The role of Blastocystis sp. And Dientamoeba fragilis in irritable bowel syndrome: a systematic review and metaanalysis. Parasitol. Res. 2017;116:22361-22371. Go to original source... Go to PubMed...
    17. Röser D, Simonsen J, Nielsen H, et al. Dientamoeba fragilis in Denmark: epidemiological experience derived from four years of routine real-time PCR. Eur. J. Clin. Microbiol. Infest. Dis. 2013;32:1303-1310. Go to original source... Go to PubMed...
    18. Ögren J, Dienus O, Löfgren S, et al. Dientamoeba fragilis DNA detection in Enterobius vermicularis eggs. Pathog. Dis. 2013;69(2):157-158. Go to original source... Go to PubMed...
    19. Audebert Ch, Even G, Cian A, et al. Colonization with the enteric protozoa Blastocystis is associated with increased diversity of human gut bacterial microbiota. Sci. Rep. 2016;6:25255. Available from: https://doi.org/10.1038/srep25255. Go to original source... Go to PubMed...
    20. Andersen L, Karam A, Roager H, et al. Associastions between common intestinal parasites and bacteria in humans ad revealed by gPCR. Eur. J. Clin. Microbiol. Infect. Dis. 2016;35(9):1427-1431. Go to original source... Go to PubMed...
    21. Castañeda S, Muñoz M, Villamizar X, et al. Microbiota charakterization in Blastocystis-colonized and Blastocystis-free school age children in Colombia. Parasit. Vectors. 2020;13(1):521. Go to original source... Go to PubMed...

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.